NOVO.B.DK

455.9

-2.2%↓

GMAB.DK

1,388.5

-0.47%↓

ZEAL.DK

453.5

-0.46%↓

AMBUB.DK

101.3

-0.78%↓

NOVO.B.DK

455.9

-2.2%↓

GMAB.DK

1,388.5

-0.47%↓

ZEAL.DK

453.5

-0.46%↓

AMBUB.DK

101.3

-0.78%↓

NOVO.B.DK

455.9

-2.2%↓

GMAB.DK

1,388.5

-0.47%↓

ZEAL.DK

453.5

-0.46%↓

AMBUB.DK

101.3

-0.78%↓

NOVO.B.DK

455.9

-2.2%↓

GMAB.DK

1,388.5

-0.47%↓

ZEAL.DK

453.5

-0.46%↓

AMBUB.DK

101.3

-0.78%↓

NOVO.B.DK

455.9

-2.2%↓

GMAB.DK

1,388.5

-0.47%↓

ZEAL.DK

453.5

-0.46%↓

AMBUB.DK

101.3

-0.78%↓

Search

Coloplast A-S (Class B)

Geschlossen

635 -1.21

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

634.8

Max

637.6

Schlüsselkennzahlen

By Trading Economics

Einkommen

-132M

912M

Verkäufe

-96M

6.9B

KGV

Branchendurchschnitt

31.716

53.54

EPS

4.046

Dividendenrendite

3.45

Gewinnspanne

13.16

Angestellte

16,741

EBITDA

-42M

2.2B

Empfehlungen

By TipRanks

Empfehlungen

Neutral

12-Monats-Prognose

+11.86% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

3.45%

2.44%

Nächstes Ergebnis

19. Aug. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-13B

144B

Vorheriger Eröffnungskurs

636.21

Vorheriger Schlusskurs

635

Coloplast A-S (Class B) Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

31. Mai 2025, 10:30 UTC

Top News

Pension Funds Won't Save the Bond Market -- Heard on the Street -- WSJ

31. Mai 2025, 06:30 UTC

Ergebnisse

5 Things We've Learned From Retail Earnings -- Barrons.com

31. Mai 2025, 04:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

30. Mai 2025, 23:51 UTC

Akquisitionen, Fusionen, Übernahmen

Trump Raises Steel Tariffs, Saying U.S. Steel Will Remain U.S.-Controlled -- Update

30. Mai 2025, 21:30 UTC

Top News

Stocks Shrug Off Trade War to Post Best Month Since 2023 -- WSJ

30. Mai 2025, 21:15 UTC

Top News

The Score: E.l.f. Beauty, Tesla, Nvidia, and More Stocks That Defined the Week -- WSJ

30. Mai 2025, 20:50 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Health Care Roundup: Market Talk

30. Mai 2025, 20:44 UTC

Akquisitionen, Fusionen, Übernahmen

Bill Ackman Is Killing It. A New ETF Will Track His Investments. -- Barrons.com

30. Mai 2025, 20:24 UTC

Top News

Major U.S. Stock Indexes Finish About Flat; U.S.-China Trade Friction Renews -- WSJ

30. Mai 2025, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

30. Mai 2025, 19:44 UTC

Market Talk

Gold Breaks 4-Month Winning Streak -- Market Talk

30. Mai 2025, 19:38 UTC

Market Talk

Companies Delay or Cancel $14B In Clean-Energy Investments -- Market Talk

30. Mai 2025, 19:29 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

NRG Energy and UnitedHealth Are the S&P 500's Best and Worst for May. Here's Why. -- Barrons.com

30. Mai 2025, 19:14 UTC

Market Talk

Oil Settles Lower Ahead of OPEC+ Output Decision -- Market Talk

30. Mai 2025, 19:05 UTC

Market Talk

U.S. Natural Gas Futures Fall Awaiting Hotter Weather -- Market Talk

30. Mai 2025, 18:51 UTC

Market Talk

Canada's Retaliatory Tariffs Help Fuel Sizable Rise in Tax Revenue -- Market Talk

30. Mai 2025, 18:37 UTC

Market Talk
Ergebnisse

Costco Well Positioned for Sustainable Growth, UBS Says -- Market Talk

30. Mai 2025, 18:04 UTC

Top News

S&P 500 Falls After More Trump-China Friction -- WSJ

30. Mai 2025, 17:47 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

30. Mai 2025, 17:47 UTC

Market Talk

Time for BoC Gov. Macklem to Cut Rates, Desjardins Says -- Market Talk

30. Mai 2025, 17:40 UTC

Akquisitionen, Fusionen, Übernahmen

Trump Is Praising His U.S. Steel Deal. No One Is Sure What It Means -- WSJ

30. Mai 2025, 17:38 UTC

Market Talk

U.S: Oil Rig Count Falls for Fifth Straight Week -- Market Talk

30. Mai 2025, 17:31 UTC

Market Talk

Costco Well Positioned to Gain Share Amid Tariffs, Baird Says -- Market Talk

30. Mai 2025, 17:14 UTC

Top News

American Consumers Are Still Gloomy on the Economy -- 3rd Update

30. Mai 2025, 16:31 UTC

Ergebnisse

Ulta Beauty Stock Is Rising. Earnings Strength Was More Than Cosmetic. -- Barrons.com

30. Mai 2025, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

30. Mai 2025, 16:20 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Health Care Roundup: Market Talk

30. Mai 2025, 16:16 UTC

Top News

S&P 500 Falls After Trump Hits Out at China -- WSJ

30. Mai 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

30. Mai 2025, 16:14 UTC

Top News

HSBC Retreats From Banking Smaller U.S. Businesses -- WSJ

Peer-Vergleich

Kursveränderung

Coloplast A-S (Class B) Prognose

Kursziel

By TipRanks

11.86% Vorteil

12-Monats-Prognose

Durchschnitt 901.38 DKK  11.86%

Hoch 1,056 DKK

Tief 720 DKK

Basierend auf 8 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Coloplast A-S (Class B) – Dist angeboten haben.

Rating-Konsens

By TipRanks

Neutral

8 ratings

2

Buy

4

Halten

2

Sell

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.